Propanc Biopharma (PPCB) Enterprise Value: 6.663M

Propanc Biopharma, Inc. (PPCB)

2.11 -0.32 (-13.17%) USD | NASDAQ | Oct 28, 16:00

2.23 +0.12 (+5.69%) After-Hours: 06:30

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2012. Start Trial.

Date	Value
October 28, 2026	6.663M
October 27, 2026	7.722M
October 26, 2026	7.259M
October 23, 2026	8.947M
October 22, 2026	8.749M
October 21, 2026	10.12M
October 20, 2026	10.30M
October 19, 2026	0.7266M
October 16, 2026	0.8094M
October 15, 2026	0.8077M
October 14, 2026	0.8879M
October 13, 2026	1.043M
October 12, 2026	1.134M
October 09, 2026	1.285M
October 08, 2026	1.236M
October 07, 2026	1.328M
October 06, 2026	1.304M
October 05, 2026	1.332M
October 02, 2026	1.357M
October 01, 2026	1.336M
September 30, 2026	1.313M
September 29, 2026	1.373M
September 28, 2026	1.443M
September 25, 2026	1.764M
September 24, 2026	1.670M

Date	Value
September 23, 2026	1.756M
September 22, 2026	1.832M
September 21, 2026	1.762M
September 18, 2026	1.697M
September 17, 2026	1.763M
September 16, 2026	1.780M
September 15, 2026	2.392M
September 14, 2026	2.491M
September 11, 2026	2.726M
September 10, 2026	2.798M
September 09, 2026	2.955M
September 08, 2026	3.087M
September 04, 2026	3.021M
September 03, 2026	3.054M
September 02, 2026	3.087M
September 01, 2026	3.418M
August 31, 2026	4.147M
August 28, 2026	4.147M
August 27, 2026	7.060M
August 26, 2026	3.220M
August 25, 2026	3.418M
August 24, 2026	3.501M
August 21, 2026	3.253M
August 20, 2026	3.319M
August 19, 2026	3.451M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks